We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cell Signaling Insights Leveraged for Glaucoma and Cancer Therapy Development

Article   Mar 18, 2020 | By Michele Wilson, PhD

 
Cell Signaling Insights Leveraged for Glaucoma and Cancer Therapy Development
 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

COVID-19: Screening Antiviral Drugs Using SARS-CoV-2 Infection Models

Article

Researchers from Queen’s University Belfast will screen approximately 1,000 drugs, which have already received regulatory approval for other indications, to ascertain if they can reduce virus infection or replication and virus-induced inflammatory responses in airway epithelial cell models and to determine if they can therefore be repurposed to treat COVID-19 patients.

READ MORE

COVID-19 – Accelerating Vaccine Development and Manufacturing

Article

Technology Networks spoke with Dr Paul Hodgson, Associate Director of Business Development at VIDO-InterVac to learn more about their experience working with coronaviruses, the organization's manufacturing facilities, and the other antivirals and therapeutics they are currently testing in relation to COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE